ISB News

Dissecting Mosquitoes is Hard!

Dr. Kristian Swearingen, ISB research scientist.

Photo by Hsiao-Ching Chou

Dr. Kristian Swearingen is a research scientist in the Moritz Lab at ISB. He and his collaborators just published a paper in PLOS Pathogens that describes potential new targets for malaria vaccines. Read his article about the research. Asked about the challenge of having to dissect thousands of mosquitoes, he commented:

When we started this project, my collaborators collected all the parasites and I focused on the mass spectrometry, so I really didn’t appreciate how difficult it is to dissect a mosquito. Since then, I’ve been training to become a parasitologist. Now I can tell you from personal experience that it is not a trivial feat. You have to look at the mosquito under a microscope and use needles to carefully remove the head and squish out the salivary glands, then somehow get the tiny glob of guts into a test tube. It takes me an average of 1 minute per mosquito. The experts are much faster than I am, but it still took a long time to get enough parasites for the experiments.

This is the second proteomics of malaria paper I’ve co-authored with Scott Linder (formerly a post-doc in the lab of Stefan Kappe at CIDResearch and now a professor at Penn State). The collaboration was born over beers at an ISB/CIDResearch joint post-doc social. I was complaining that I had really cool technology but no interesting samples, and Scott said “I have an interesting sample for you!” I had always wanted to work on diseases affecting the developing world, but as an analytical chemist, my research up to that point was focused on technology development. This collaboration finally gave me a chance to work on malaria, and I used that experience to win a training award from the NIH specifically designed to bring technologists like me into the field of biological research. Now I have a chance to make a career out of applying cutting-edge technology to neglected diseases.

Recent Articles

  • In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

    Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.

  • The Gut Microbiome’s Supersized Role In Shaping Our Metabolome

    ISB researchers have shown which blood metabolites are associated with the gut microbiome, genetics, or the interplay between both. Their findings, published in the journal Nature Metabolism, have promising implications for guiding targeted therapies designed to alter the composition of the blood metabolome to improve human health.

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.